20% Prosol 1.02 g (Glutamic Acid LIQUID) 1.02 G

20% PROSOL 1.02 G is a liquid intravenous solution containing 1.02 grams of glutamic acid per 100 mL. This pharmaceutical product is designed for medical use and is manufactured by Baxter Corporation in Canada.

Strength

1.02 G

Pack Size

500/1000/2000ML

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Glutamic acid is an amino acid that plays a crucial role in various bodily functions. 20% PROSOL 1.02 G is commonly used in medical settings for nutritional support, particularly in patients who require intravenous administration of amino acids. It may be used to support metabolic processes and overall health in individuals who cannot consume nutrients orally.

Side Effects

When administered intravenously, 20% PROSOL 1.02 G provides essential amino acids to the body. This can help support protein synthesis and other metabolic functions. Patients may experience improved nutritional status and overall well-being when used as directed by a healthcare professional.

Precautions & Warnings

As with any intravenous solution, it is important to follow proper administration guidelines to avoid complications. Patients should be monitored for any adverse reactions. This product should only be used under the supervision of a healthcare professional.

Avoid Interactions

Glutamic acid may interact with certain medications or supplements. It is important to inform your healthcare provider about all medications you are taking before starting treatment with 20% PROSOL 1.02 G. Always consult with a healthcare professional for personalized advice.

Frequently Asked Questions

20% PROSOL 1.02 G is used for nutritional support, particularly in patients who require intravenous administration of amino acids.

20% PROSOL 1.02 G is administered intravenously under the supervision of a healthcare professional.

Common effects include support for protein synthesis and overall metabolic functions, leading to improved nutritional status.

Yes, it is important to follow proper administration guidelines and monitor for any adverse reactions. Use only under healthcare professional supervision.

Yes, glutamic acid may interact with certain medications or supplements. Consult a healthcare professional for personalized advice.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.